Has Christopher Tully received payments from drug or device companies?

Yes. Drug and device makers reported $17,494 in general payments to Christopher Tully across 1,097 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Tully did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Tully come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Tully

Hematology · Mountain Lakes, NJNPI 1053585232

Payments from drug & device makers

$17,494in general payments, 2019–2025

Across 1,097 payments — averaging $15.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$2K
Seagen Inc.$2K
E.r. Squibb & Sons, L.L.C.$1K
Novartis$1K
Merck$946
Johnson & Johnson$930
plus $10K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	106	$1,815
Seagen Inc.	32	$1,587
E.r. Squibb & Sons, L.L.C.	100	$1,403
Novartis	80	$1,038
Merck	68	$946
Johnson & Johnson(2 entities)	68	$930
Incyte Corporation	60	$873
Amgen(2 entities)	69	$813
Daiichi Sankyo Inc.	34	$567
GSK	31	$500
Genentech USA, Inc.	34	$479
Bayer	29	$413
Eisai Inc.	18	$384
Astellas Pharma US Inc	24	$344
Gilead(2 entities)	20	$329
Sanofi	21	$319
AbbVie	21	$304
Ipsen Biopharmaceuticals, Inc	12	$299
Bristol Myers Squibb	22	$295
Regeneron Healthcare Solutions, Inc.	17	$262
Pfizer	16	$233
Lilly USA, LLC	19	$188
Puma Biotechnology, Inc.	14	$171
Mirati Therapeutics, Inc.	10	$161
Foundation Medicine, Inc.	5	$145
Verastem, Inc.	9	$142
Takeda Pharmaceuticals U.S.A., Inc.	9	$140
Kyowa Kirin, Inc.	9	$136
Celltrion USA Inc.	2	$129
Pharmacyclics LLC, An Abbvie Company	9	$126
Taiho Oncology, Inc.	6	$107
Blueprint Medicines Corporation	6	$105
Beigene USA, Inc.	7	$104
Myriad Genetic Laboratories, Inc.	6	$96
Exelixis Inc.	6	$94
Genmab U.S., Inc.	6	$93
Karyopharm Therapeutics Inc.	6	$93
Boehringer Ingelheim	6	$84
Pharmacosmos Therapeutics Inc.	5	$81
CTI Biopharma Corp.	5	$72
AMAG Pharmaceuticals, Inc.	5	$64
Pharmaessentia USA Corporation	4	$63
Adaptive Biotechnologies Corporation	4	$62
EMD Serono, Inc.	4	$59
Rigel Pharmaceuticals, Inc.	4	$56
AVEO Pharmaceuticals, Inc.	3	$55
Servier Pharmaceuticals LLC	3	$54
Array Biopharma Inc	3	$49
Epizyme, Inc.	3	$43
Immunogen, Inc.	3	$43
Teva Pharmaceuticals USA, Inc.	3	$42
Myovant Sciences Inc.	2	$38
Partner Therapeutics, Inc.	2	$36
Beone Medicines USA, Inc.	2	$35
Legend Biotech USA Inc.	2	$34
Spectrum Pharmaceuticals Inc.	2	$34
Clovis Oncology, Inc.	3	$34
Sun Pharmaceutical Industries Inc.	2	$28
EUSA Pharma (US) LLC	2	$26
Tempus AI, Inc	1	$25

How this compares

$17,494 in reported general payments places this provider in the 65th percentile of 43 hematology providers in New Jersey.

See all hematology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$4,833,774

Medicare patients

462

Services billed

135,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Mountain Lakes

Muhammad AbbasiMountain Lakes$28K
Jason LevitzMountain Lakes$19K
Fazal BariMountain Lakes$12K
Ahmed GalalMorristown$2.1M
Mansi ShahNew Brunswick$1.7M
Rahul MatnaniRutherford$175K
Fermina MazzellaNewark$89K
Ogechukwu EginiNew Brunswick$89K
Claire PhilippNew Brunswick$53K
Girish AminBrick$51K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →